Health ❯Chronic Diseases ❯Diabetes ❯Treatment Options

Ozempic

Novo Nordisk Cuts 9,000 Jobs as It Lowers 2025 Margin Outlook

Novo cites intensifying competition in obesity treatments, prompting a pivot to performance-focused investment.

Novo Nordisk CEO Steps Down Following Share Price Collapse

Bernie Sanders Pushes for Cheaper Ozempic Amid Medicare Price Negotiations